Napco安全技术 NSSC 深 沪
等待开盘 11-06 09:30:00 美东时间
44.07
+2.720
+6.58%
华盛通- 最 高44.10
- 今 开41.28
- 成交量 22.29万股
- 最 低 41.28
- 昨 收 41.35
- 总市值 15.72亿
- 52周最高 48.12
- 市盈率 静 37.06
- 换手率 0.63%
- 52周最低 18.72
- 委 比 60.94%
- 总股本 3566.43万
- 历史最高 57.435
- 量 比 0.69
- 振 幅 6.82%
- 历史最低 -0.1775
- 每 手 1
- 风险率 6.98%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 最高255美元！9家大行集体上调Palantir目标价；Axsome、Exact、Fabrinet、ZoomInfo、爱德士、MongoDB、安森美半导体等也获多家大行上调目标价
今日重点评级关注：瑞银：维持Syndax Pharmaceuticals"买入"评级，目标价从35美元升至38美元；HC Wainwright & Co.：维持Benitec Biopharma"买入"评级，目标价从28美元升至35美元
11-05 10:35
Needham Maintains Buy on NAPCO Security Techs, Raises Price Target to $47
Needham analyst James Ricchiuti maintains NAPCO Security Techs (NASDAQ:NSSC) with a Buy and raises the price target from $36 to $47.
11-04 18:27
Napco Security Technologies, Inc. declares $0.14 dividend
Napco Security Technologies, Inc. (NSSC) declares $0.14/share quarterly dividend, in line with previous. Payable Jan. 2; for shareholders of record Dec. 12; ex-div Dec. 12. See NSSC Dividend Scorecard...
11-04 14:23
Napco Security Technologies Reports Record Q1 2026 Revenue
Napco Security Technologies ( ($NSSC) ) just unveiled an update. On November 3,...
11-04 02:28
NAPCO Security Technologies shares are trading lower. The company reported Q1 financial results.
NAPCO Security Technologies shares are trading lower. The company reported Q1 f...
11-04 02:07
NAPCO Security Techs Q1 EPS $0.34 Beats $0.30 Estimate, Sales $49.168M Beat $46.870M Estimate
NAPCO Security Techs (NASDAQ:NSSC) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.30 by 12.58 percent. This is a 13.33 percent increase over earnings of $0.30 per share
11-03 20:01
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
11-03 19:11
What's Next: NAPCO Security Techs's Earnings Preview
NAPCO Security Techs (NASDAQ:NSSC) will release its quarterly earnings report o...
11-01 04:02
美股大行评级 | 潜在最高涨幅37.45%，甲骨文获多家机构上调目标价；瑞穗上调美光科技目标价升至240美元
今日重点评级关注：韦德布什：维持Artiva Biotherapeutics"跑赢大市"评级，目标价从18美元升至23美元；巴克莱：维持Cellectis"超配"评级，目标价从4美元升至8美元
10-20 10:03
美股大行评级 | 伯恩斯坦上调阿里巴巴目标价升至200美元；麦格理上调百度评级至"跑赢大市"，目标价升至176美元
今日重点评级关注：摩根大通：维持National Energy Services"超配"评级，目标价从10美元升至19美元；Piper Sandler：维持LENZ Therapeutics"超配"评级，目标价从51美元升至67美元
10-13 11:26
